VST LLC
Brookings, SD Doing business as Medgene Labs
- UEI
- C1BBMYGKVUH5
- CAGE
- 648V1
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 1006 32nd Ave, Brookings, SD 57006, USA
- Website
- medgenelabs.com
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
Grant awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Iowa State University Of Science And Technology | AP24VSSP0000C104 | $182,321 |
Similar vendors
About the company
VST LLC, doing business as Medgene Labs, is a South Dakota-based veterinary biotechnology firm that develops vaccines for livestock pathogens as the prime recipient of federal research grants from the U.S. Department of Agriculture and Department of Homeland Security, with secondary engagement as a sub-recipient on infectious-disease vaccine research awards.
Medgene Labs is structured as a limited liability partnership headquartered in Brookings, South Dakota, and operates predominantly as a prime grant recipient (88% of awards). The vendor's federal footprint centers on biotechnology R&D and applied research in animal health, particularly vaccine development targeting economically significant livestock pathogens. The company's capability portfolio focuses on baculovirus-vector-derived vaccine development, field safety studies, vaccine formulation, and mechanism-of-action validation in cattle and small ruminants.
The Department of Agriculture's National Institute of Food and Agriculture is the dominant customer by award count (2 awards), while the Department of Homeland Security Science and Technology Directorate anchors the highest-dollar individual award at $750 thousand. Two primary-recipient grants illustrate Medgene's core work: a Phase II grant from USDA NIFA awarded September 1, 2024, with completion August 31, 2027, to develop the first U.S.-based Asian longhorned tick anti-tick vaccine as a 2-dose baculovirus-derived regimen; and a Phase I grant from USDA NIFA awarded July 1, 2023 (completion June 30, 2024) on the same subject, focused on vaccine development and immunogenicity assessment. As a sub-recipient under Iowa State University on a USDA NIFA award dated October 24, 2024, Medgene Labs is conducting field safety studies and vaccine formulation work for bluetongue virus, RSV, and CVV vaccines in sheep and goat populations.
Activity is intermittent rather than sustained: two awards in 2024, one in 2023, and no awards recorded between 2015 and 2023. Combined obligated dollars ($2.2 million) exceed combined potential value ($1.2 million), indicating awards that have been fully or overfunded relative to their initial ceiling estimates. One award faces completion within the next twenty-four months.
Quick answers
Is VST LLC registered in SAM.gov?
Yes. VST LLC's SAM.gov registration is active through May 26, 2027.
What is VST LLC's most recent federal award?
VST LLC's most recent federal grant award is Awards issued prior to january 20, 2025, were funded under previous administrations and may not reflect the… (20243361043204), from Institute of Food Production and Sustainability (NIFA), on September 1, 2024.
On GovTribe
See VST LLC's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors